These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27016045)

  • 21. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
    Wang J; Zhou X; Liu Y; Li Z; Li X
    PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis.
    Li H; Zhao Y; Zheng F
    Medicine (Baltimore); 2019 Jan; 98(3):e14126. PubMed ID: 30653142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Zhang N; Zhang H; Zhu D; JiRiGaLa ; Yu D; Wang C; WuYunBiLiGe ; Amin ; ZhiHong ; Yu H; Chen X; Wang M
    Int J Surg; 2020 Jul; 79():66-73. PubMed ID: 32417461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-angiogenic therapies for metastatic colorectal cancer.
    Wagner AD; Arnold D; Grothey AA; Haerting J; Unverzagt S
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005392. PubMed ID: 19588372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
    Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
    Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis.
    Shui L; Wu YS; Lin H; Shui P; Sun Q; Chen X
    Cell Physiol Biochem; 2018; 48(5):1870-1881. PubMed ID: 30092572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis.
    Zhang Q; Gong X; Sun L; Miao L; Zhou Y
    Front Oncol; 2022; 12():791496. PubMed ID: 35924149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials.
    Liang RF; Zheng LL
    Drug Des Devel Ther; 2015; 9():4471-8. PubMed ID: 26300630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials.
    Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Barni S
    Med Oncol; 2013; 30(3):650. PubMed ID: 23828442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
    Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis.
    Groot Koerkamp B; Rahbari NN; Büchler MW; Koch M; Weitz J
    Ann Surg Oncol; 2013 Jul; 20(7):2156-65. PubMed ID: 23456317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral versus intravenous fluoropyrimidines for colorectal cancer.
    Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
    Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
    Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-line systemic therapy for metastatic colorectal cancer.
    Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral monocyte counts predict the clinical outcome for patients with colorectal cancer: a systematic review and meta-analysis.
    Wen S; Chen N; Peng J; Ling W; Fang Q; Yin SF; He X; Qiu M; Hu Y
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1313-1321. PubMed ID: 31567616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis.
    Li J; Li S; Chen R; Yu H; Lu X
    J Ovarian Res; 2015 Aug; 8():54. PubMed ID: 26242216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis.
    Cai J; Ma H; Huang F; Zhu D; Bi J; Ke Y; Zhang T
    World J Surg Oncol; 2013 Nov; 11():306. PubMed ID: 24283603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.